Target intelligence / Profile preview

Oral bacterial biofilm (OBB) (OBB)

Target
OBB
Molecular classification
Other
01

Overview

Oral bacterial biofilms are complex, multi-species microbial communities that adhere to oral surfaces and are encased in a self-produced matrix of extracellular polymeric substances (EPS) (Bowen et al., 2018). These biofilms represent a highly organized form of microbial life, facilitating metabolic cooperation, horizontal gene transfer, and enhanced resistance to host immune defenses and antimicrobial treatments (Marsh, 2006). While the oral microbiome typically exists in a symbiotic relationship with the host, environmental changes can trigger a shift toward pathogenic species, leading to the development of dental caries, gingivitis, and periodontitis (Karygianni et al., 2020). Beyond local oral diseases, these biofilms can serve as reservoirs for pathogens that enter the systemic circulation, potentially contributing to conditions such as infective endocarditis and cardiovascular disease (Seneviratne et al., 2011). Therapeutic strategies aimed at oral biofilms include mechanical disruption through brushing and scaling, as well as chemical interventions using agents like chlorhexidine, fluoride, and cetylpyridinium chloride (StatPearls, 2023). These agents work by disrupting bacterial cell membranes, inhibiting metabolic enzymes, or interfering with the structural integrity of the EPS matrix to prevent biofilm maturation and promote clearance (Karygianni et al., 2020).

Other names
Dental plaqueDental biofilmOral biofilmSubgingival biofilmSupragingival biofilm
02

Mechanism of action

Disruption of cell membranes, inhibition of bacterial metabolism, and degradation of the extracellular polymeric substance (EPS) matrix.

03

Biological functions

Immune responseOther
04

Disease associations

InfectionInflammationCardiovascular diseaseOther
05

Safety considerations

Antimicrobial resistanceOral dysbiosisTooth stainingMucosal irritation
06

Interacting drugs

Chlorhexidine

6 more in the full profile.

07

Biomarkers

Plaque IndexStreptococcus mutans levelsPorphyromonas gingivalis levelsExtracellular polysaccharide (EPS) concentration

Beyond the preview

Go deeper on Oral bacterial biofilm (OBB) (OBB).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Oral bacterial biofilm (OBB) (OBB).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call